Quick Answer
Syra Health Corp reported Total Revenue of $7.23 million for fiscal year 2025.
Syra Health Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $7.23M -9.5% |
$7.98M +44.7% |
$5.52M -1.8% |
$5.62M | — |
| Revenue (ASC 606) | $7.23M -9.5% |
$7.98M +44.7% |
$5.52M -1.8% |
$5.62M | — |
| Net Income | -$896.3K +76.2% |
-$3.76M -27.9% |
-$2.94M -38.7% |
-$2.12M | — |
| Diluted EPS | -$0.08 +84.0% |
-$0.50 +16.7% |
-$0.60 +14.3% |
-$0.70 | — |
| Total Assets | $2.77M -24.6% |
$3.68M -25.3% |
$4.92M +112.2% |
$2.32M | — |
| Cash and Equivalents | $1.61M -32.6% |
$2.40M -27.0% |
$3.28M | — | — |
| Stockholders Equity | $2.10M -27.1% |
$2.88M -28.3% |
$4.01M +465.2% |
$710.1K +10035.6% |
-$7.1K |
| R&D Expense | $67.8K -88.4% |
$585.1K +143.8% |
$240.0K | — | — |
| Operating Income | -$904.3K +76.0% |
-$3.76M -30.4% |
-$2.89M -38.2% |
-$2.09M | — |
| Gross Profit | $2.49M +50.5% |
$1.65M +17.1% |
$1.41M +33.0% |
$1.06M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.69M | -25.1% | -13.3% |
| Revenue (ASC 606) | September 30, 2025 | $1.69M | -25.1% | -13.3% |
| Net Income | September 30, 2025 | -$225.9K | +45.9% | -255.2% |
| Diluted EPS | September 30, 2025 | -$0.02 | +66.7% | -100.0% |
| Total Assets | September 30, 2025 | $3.26M | -26.3% | -6.0% |
| Cash and Equivalents | September 30, 2025 | $1.98M | — | -14.3% |
| Stockholders Equity | September 30, 2025 | $2.21M | -33.7% | -8.5% |
| R&D Expense | September 30, 2025 | $816.00 | -97.7% | -97.3% |
| Operating Income | September 30, 2025 | -$232.2K | +45.9% | -267.6% |
| Gross Profit | September 30, 2025 | $554.5K | -17.0% | -26.3% |
- Syra Health Corp reported Total Revenue of $7.23 million for fiscal year 2025.
- Syra Health Corp showed a decrease of -9.5% in Total Revenue compared to the prior fiscal year.
- Syra Health Corp reported Revenue (ASC 606) of $7.23 million for fiscal year 2025.
- Syra Health Corp showed a decrease of -9.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Syra Health Corp reported Net Income of -$896.3 thousand for fiscal year 2025.
- Syra Health Corp showed an increase of +76.2% in Net Income compared to the prior fiscal year.
- Syra Health Corp reported Diluted EPS of $0.08 per share (loss) for fiscal year 2025.
- Syra Health Corp showed an increase of +84.0% in Diluted EPS compared to the prior fiscal year.
- Syra Health Corp reported Total Assets of $2.77 million for fiscal year 2025.
- Syra Health Corp showed a decrease of -24.6% in Total Assets compared to the prior fiscal year.
- Syra Health Corp reported Cash and Equivalents of $1.61 million for fiscal year 2025.
- Syra Health Corp showed a decrease of -32.6% in Cash and Equivalents compared to the prior fiscal year.
- Syra Health Corp reported Stockholders Equity of $2.10 million for fiscal year 2025.
- Syra Health Corp showed a decrease of -27.1% in Stockholders Equity compared to the prior fiscal year.
- Syra Health Corp reported R&D Expense of $67.8 thousand for fiscal year 2025.
- Syra Health Corp showed a decrease of -88.4% in R&D Expense compared to the prior fiscal year.
- Syra Health Corp reported Operating Income of -$904.3 thousand for fiscal year 2025.
- Syra Health Corp showed an increase of +76.0% in Operating Income compared to the prior fiscal year.
- Syra Health Corp reported Gross Profit of $2.49 million for fiscal year 2025.
- Syra Health Corp showed an increase of +50.5% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: